Companies / Bicara Therapeutics Inc. / Activity
Activity — Bicara Therapeutics Inc.
22 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | Mazumdar Claire CEO | Sell | Common Stock | $704.7K | -37K -9.77% | 339,392 0.51% of shares | medium |
| Mar 9, 2026 | Mazumdar Claire CEO | Exercise | Common Stock | $139.3K | +37K +10.83% | 376,158 0.57% of shares | low |
| Mar 19, 2026 | Mazumdar Claire CEO | Sell | Common Stock | $129.7K | -7K -1.99% | 339,392 0.51% of shares | medium |
| Mar 18, 2026 | Mazumdar Claire CEO | Sell | Common Stock | $122.4K | -6K -1.88% | 339,392 0.51% of shares | medium |
| Mar 6, 2026 | Mazumdar Claire CEO | Sell | Common Stock | $71.6K | -4K -1.11% | 339,392 0.51% of shares | low |
| Mar 4, 2026 | Mazumdar Claire CEO | Sell | Common Stock | $49.3K | -3K -0.77% | 339,392 0.51% of shares | low |
| Mar 5, 2026 | Mazumdar Claire CEO | Sell | Common Stock | $33.5K | -2K -0.52% | 339,392 0.51% of shares | low |
| Mar 20, 2026 | Mazumdar Claire CEO | Sell | Common Stock | $30.2K | -2K -0.47% | 339,392 0.51% of shares | low |
| Mar 19, 2026 | Mazumdar Claire CEO | Exercise | Common Stock | $26.2K | +7K +2.03% | 346,297 0.52% of shares | low |
| Mar 18, 2026 | Mazumdar Claire CEO | Exercise | Common Stock | $24.6K | +6K +1.91% | 345,891 0.52% of shares | low |
| Mar 6, 2026 | Mazumdar Claire CEO | Exercise | Common Stock | $14.5K | +4K +1.12% | 343,209 0.52% of shares | low |
| Mar 4, 2026 | Mazumdar Claire CEO | Exercise | Common Stock | $10.0K | +3K +0.78% | 342,023 0.52% of shares | low |
| Mar 5, 2026 | Mazumdar Claire CEO | Exercise | Common Stock | $6.8K | +2K +0.53% | 341,178 0.52% of shares | low |
| Mar 20, 2026 | Mazumdar Claire CEO | Exercise | Common Stock | $6.0K | +2K +0.47% | 340,988 0.52% of shares | low |
| Mar 20, 2026 | Mazumdar Claire CEO | Exercise | Stock Option (Right to Buy) | — | -2K -0.90% | 176,107 0.27% of shares | low |
| Mar 19, 2026 | Mazumdar Claire CEO | Exercise | Stock Option (Right to Buy) | — | -7K -3.74% | 177,703 0.27% of shares | low |
| Mar 18, 2026 | Mazumdar Claire CEO | Exercise | Stock Option (Right to Buy) | — | -6K -3.40% | 184,608 0.28% of shares | low |
| Mar 9, 2026 | Mazumdar Claire CEO | Exercise | Stock Option (Right to Buy) | — | -37K -16.13% | 191,107 0.29% of shares | low |
| Mar 6, 2026 | Mazumdar Claire CEO | Exercise | Stock Option (Right to Buy) | — | -4K -1.65% | 227,873 0.34% of shares | low |
| Mar 5, 2026 | Mazumdar Claire CEO | Exercise | Stock Option (Right to Buy) | — | -2K -0.77% | 231,690 0.35% of shares | low |
| Mar 4, 2026 | Mazumdar Claire CEO | Exercise | Stock Option (Right to Buy) | — | -3K -1.11% | 233,476 0.35% of shares | low |
| Feb 2, 2026 | Mazumdar Claire CEO | Grant | Stock Option (Right to Buy) | — | +450K | 450,000 0.68% of shares | low |